Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 20,000 shares at an average $0.19 ($3,845)
  2. 4 Grant or award Director acquired 2,500 shares (grant or award)
  3. 4 Grant or award Director acquired 2,500 shares (grant or award)
  4. 4 Grant or award Dir Govt Relations/Sectry acquired 2,500 shares (grant or award)
  5. 4 Grant or award Exec. Vice Chairman/CEO/Pres. acquired 2,500 shares (grant or award)
  6. 4 Grant or award Chief Science/Medical Officer acquired 2,500 shares (grant or award)
  7. 4 Grant or award Sr. VP of Operations acquired 2,500 shares (grant or award)
  8. 4 Grant or award CFO acquired 2,500 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Director bought 25,238 shares at $0.22 ($5,552)
  15. 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 3,500 shares at $0.20 ($711)
  16. 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 100,000 shares at $0.20 ($20,000)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 31 · 615 filings